A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients

Citation
J. Ongradi et al., A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients, J NEUROVIRO, 5(5), 1999, pp. 529-532
Citations number
22
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF NEUROVIROLOGY
ISSN journal
13550284 → ACNP
Volume
5
Issue
5
Year of publication
1999
Pages
529 - 532
Database
ISI
SICI code
1355-0284(199910)5:5<529:APSOTA>2.0.ZU;2-N
Abstract
In the possible role for human herpesviruses (HHV) in the pathogenesis of m ultiple sclerosis (MS) neither clear distinction between the two variants o f HHV-6, nor the involvement of HHV-7 have been described. Therefore, we qu antitated HHV-6 variant specific and HHV-7 reacting antibodies in the CSF o f 13 patients with MS or other neurological disorders by ELISA. Predominanc e in the positivity of IgG (67%) and IgM (44%) to HHV-6B over that of IgG ( 44%) with no detectable IgM to HHV-6A, and no antibodies to HHV-7 were foun d in the CSF of MS patients. None of these antibodies were found in the CSF of controls. This suggests that, intrathecal chronic active or primary HHV -6B infection might contribute to MS progression, while the local effects o f HHV-6A and HHV-7 seem to be less important.